Tejal A. Desai
University of California, San Francisco
366 Papers
3.1K Citations
Tejal A. Desai is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Drug delivery & Chemistry. The author has an hindex of 73, co-authored 348 publications. Previous affiliations of Tejal A. Desai include Stanford University & University of Illinois at Urbana–Champaign.
Chat about Author
Papers
Retinal tissue engineering using mouse retinal progenitor cells and a novel biodegradable, thin-film poly(e-caprolactone) nanowire scaffold.
Stephen Redenti,Sarah L. Tao,Jing Yang,Ping Gu,Henry Klassen,Sunita Saigal,Tejal A. Desai,Michael J. Young +7 more
TL;DR: Evidence is provided that RPCs proliferate and express mature retinal proteins in response to interactions with nanowire scaffolds, which allow for the migration and differentiation of new cells into normal and degenerated retina.
Engineering the drug carrier biointerface to overcome biological barriers to drug delivery
TL;DR: This review examines how key material design parameters lead to dynamic biointerfaces and improved drug delivery across biological barriers and how biointerface engineering can enable drug carriers to better navigate and overcome these barriers to drug delivery.
141
Vascular tissue engineering: microtextured scaffold templates to control organization of vascular smooth muscle cells and extracellular matrix.
TL;DR: It is suggested that topographical patterning of tissue scaffolds can influence cellular and matrix spatial organization and could provide a framework for achieving the required organization and physical properties for blood vessels.
138
Patent
Implantable analyte sensor
Matthias Essenpreis,Tejal A. Desai,Mauro Ferrari,Derek J. Hansford +3 more
- 16 Mar 2001
TL;DR: An implantable analyte sensor includes a substrate, electrodes on the substrate, and a membrane on the electrodes as discussed by the authors, which can comprise elemental silicon and has a glucose diffusion test result of at least 1 mg/dl in 330 min.
133
The Psychiatric Cell Map Initiative: A Convergent Systems Biological Approach to Illuminating Key Molecular Pathways in Neuropsychiatric Disorders.
A. Jeremy Willsey,Montana T. Morris,Sheng Wang,Helen Rankin Willsey,Nawei Sun,Nia Teerikorpi,Tierney Baum,Gerard Cagney,Kevin J. Bender,Tejal A. Desai,Deepak Srivastava,Deepak Srivastava,Graeme W. Davis,Jennifer A. Doudna,Edward F. Chang,Vikaas S. Sohal,Daniel H. Lowenstein,Hao Li,David A. Agard,Michael J. Keiser,Brian K. Shoichet,Mark von Zastrow,Lennart Mucke,Lennart Mucke,Steven Finkbeiner,Steven Finkbeiner,Li Gan,Li Gan,Nenad Sestan,Michael E. Ward,Ruth Hüttenhain,Ruth Hüttenhain,Tomasz J. Nowakowski,Hugo J. Bellen,Loren M. Frank,Mustafa K. Khokha,Richard P. Lifton,Martin Kampmann,Trey Ideker,Matthew W. State,Nevan J. Krogan +40 more
TL;DR: An initiative aimed at mapping the physical and genetic interaction networks of neuropsychiatric disorders and then using these maps to connect the genomic data to neurobiology and, ultimately, the clinic is described.
129